Loading...

NeonMind Biosciences Inc.

NMDBF•PNK
HealthcareBiotechnology
$0.008
$0.00(0.00%)

NeonMind Biosciences Inc. (NMDBF) Stock Overview

Explore NeonMind Biosciences Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for NMDBFStats details for NMDBF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for NMDBFAnalyst Recommendations details for NMDBF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. It is developing psilocybin-based products comprising mushroom-infused products and other mushroom-infused products to treat weight loss and management. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is based in Oakville, Canada. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp.

CEO

Ms. Penny Olga White B.A., BA, L.L.B., LLB

Headquarters

295 Robinson Street, Oakville, ON

Founded

2021

Frequently Asked Questions